Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality, with mortality rates approaching 62%. HAP and VAP are the second most common cause of nosocomial infection overall, but are the most common cause documented in the intensive c...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2008/593289 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849401999121973248 |
|---|---|
| author | Coleman Rotstein Gerald Evans Abraham Born Ronald Grossman R Bruce Light Sheldon Magder Barrie McTaggart Karl Weiss George G Zhanel |
| author_facet | Coleman Rotstein Gerald Evans Abraham Born Ronald Grossman R Bruce Light Sheldon Magder Barrie McTaggart Karl Weiss George G Zhanel |
| author_sort | Coleman Rotstein |
| collection | DOAJ |
| description | Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality, with mortality rates approaching 62%. HAP and VAP are the second most common cause of nosocomial infection overall, but are the most common cause documented in the intensive care unit setting. In addition, HAP and VAP produce the highest mortality associated with nosocomial infection. As a result, evidence-based guidelines were prepared detailing the epidemiology, microbial etiology, risk factors and clinical manifestations of HAP and VAP. Furthermore, an approach based on the available data, expert opinion and current practice for the provision of care within the Canadian health care system was used to determine risk stratification schemas to enable appropriate diagnosis, antimicrobial management and nonantimicrobial management of HAP and VAP. Finally, prevention and risk-reduction strategies to reduce the risk of acquiring these infections were collated. Future initiatives to enhance more rapid diagnosis and to effect better treatment for resistant pathogens are necessary to reduce morbidity and improve survival. |
| format | Article |
| id | doaj-art-8bdca99007fb4a08945decbfae009459 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-8bdca99007fb4a08945decbfae0094592025-08-20T03:37:38ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322008-01-01191195310.1155/2008/593289Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in AdultsColeman Rotstein0Gerald Evans1Abraham Born2Ronald Grossman3R Bruce Light4Sheldon Magder5Barrie McTaggart6Karl Weiss7George G Zhanel8Division of Infectious Diseases and Department of Medicine, McMaster University and Henderson Site, Hamilton Health Sciences, Hamilton, CanadaDivision of Infectious Diseases, Queen’s University and Kingston General Hospital, Kingston, CanadaUniversity of Toronto and North York General Hospital, Toronto, CanadaUniversity of Toronto, Toronto, Ontario and Credit Valley Hospital, Mississauga, Ontario, CanadaUniversity of Manitoba and St Boniface Hospital, Winnipeg, Manitoba, CanadaMcGill University Health Centre, Division of Critical Care and Department of Medicine, Royal Victoria Hospital, Montreal, Quebec, CanadaMcMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, CanadaDepartment of Microbiology and Infectious Diseases, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, CanadaDepartment of Medical Microbiology, Faculty of Medicine, University of Manitoba, CanadaHospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality, with mortality rates approaching 62%. HAP and VAP are the second most common cause of nosocomial infection overall, but are the most common cause documented in the intensive care unit setting. In addition, HAP and VAP produce the highest mortality associated with nosocomial infection. As a result, evidence-based guidelines were prepared detailing the epidemiology, microbial etiology, risk factors and clinical manifestations of HAP and VAP. Furthermore, an approach based on the available data, expert opinion and current practice for the provision of care within the Canadian health care system was used to determine risk stratification schemas to enable appropriate diagnosis, antimicrobial management and nonantimicrobial management of HAP and VAP. Finally, prevention and risk-reduction strategies to reduce the risk of acquiring these infections were collated. Future initiatives to enhance more rapid diagnosis and to effect better treatment for resistant pathogens are necessary to reduce morbidity and improve survival.http://dx.doi.org/10.1155/2008/593289 |
| spellingShingle | Coleman Rotstein Gerald Evans Abraham Born Ronald Grossman R Bruce Light Sheldon Magder Barrie McTaggart Karl Weiss George G Zhanel Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults |
| title_full | Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults |
| title_fullStr | Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults |
| title_full_unstemmed | Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults |
| title_short | Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults |
| title_sort | clinical practice guidelines for hospital acquired pneumonia and ventilator associated pneumonia in adults |
| url | http://dx.doi.org/10.1155/2008/593289 |
| work_keys_str_mv | AT colemanrotstein clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT geraldevans clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT abrahamborn clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT ronaldgrossman clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT rbrucelight clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT sheldonmagder clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT barriemctaggart clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT karlweiss clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults AT georgegzhanel clinicalpracticeguidelinesforhospitalacquiredpneumoniaandventilatorassociatedpneumoniainadults |